Clinical Trial Update: Omission of Surgery for Triple-negative Breast Cancer in Complete Response After Neoadjuvant Chemo-immunotherapy [NA]

View source ↗

Summary

A clinical trial update indicates that surgery may be omitted for patients with triple-negative breast cancer who achieve complete response after neoadjuvant ch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Snippet

Sponsor: Institut Curie | Conditions: Triple Negative Breast Cancer, Non-Metastatic | NA | Status: NOT_YET_RECRUITING